ReviewCurrent hypertension reports2016
White Coat Hypertension: to Treat or Not to Treat?
Review in Current hypertension reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.Journal of veterinary internal medicine · 2018Guideline
- Circadian Urinary Excretion of Water, and Not Salt, Is Affected by the White Coat Effect.Journal of clinical medicine · 2023Article
- Prevalence of persistent hypertension and situational hypertension in a population of elderly cats in The Netherlands.Journal of feline medicine and surgery · 2023Article
- Masked Hypertension and Exaggerated Blood Pressure Response to Exercise: A Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2023Review
- Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India.Diagnostics (Basel, Switzerland) · 2022Article
- The prevalence of masked hypertension and masked uncontrolled hypertension in relation to overweight and obesity in a nationwide registry in China.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
- Telemedicine in prenatal care.Central European journal of public health · 2022Article
- Self-Monitoring Home Blood Pressure in Community-Dwelling Older People: Age Differences in White-Coat and Masked Phenomena and Related Factors-The SONIC Study.International journal of hypertension · 2022Article
- American Versus European Hypertension Guidelines: The Case of White Coat Hypertension.American journal of hypertension · 2020Article
- Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2020Review
- Labile hypertension: a new disease or a variability phenomenon?Journal of human hypertension · 2019Review
- The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2019Article
- White-coat hypertension and albuminuria; lessons from the Hisayama and Ohasama studies.Hypertension research : official journal of the Japanese Society of Hypertension · 2018Article
- Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2018Article
- White coat syndrome and its variations: differences and clinical impact.Integrated blood pressure control · 2018Review
- The differential diagnostic value of serum homocysteine for white coat hypertension.Oncotarget · 2017Article
- Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study.Journal of clinical hypertension (Greenwich, Conn.) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Definition of white coat hypertension (WCH) traditionally relies on elevated office blood pressure (BP) during repeated visits concomitant with normal out-of-office BP values, as assessed by home and/or 24-h ambulatory BP monitoring measurements. Accumulating evidence focusing on the association of WCH with target organ damage and, more importantly, with cardiovascular events indicates that the risk conveyed by this condition is intermediate between normotension and sustained hypertension. This article will review a number of issues concerning WCH with particular emphasis on the following: (1) prevalence and clinical correlates, (2) association with target organ damage and cardiovascular events, (3) therapeutic interventions. Data will refer to the original WCH definition, based on out-of-office BP determined by 24-h ambulatory BP monitoring; at variance from home BP measurement, this approach rules out the potentially confounding effect of a clinically relevant abnormal BP phenotype such as isolated nocturnal hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.